Four firms work on pharmaceutical acquisition
Montreal-based Valeant Pharmaceuticals International Inc., which develops dermatology and neurology therapeutic products, announced Sept. 3 it is purchasing Scottsdale, Ariz.-based competitor Medicis Pharmaceutical Corp. for $2.6 billion. Sullivan & Cromwell LLP and Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates represented Valeant. Los Angeles part...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In